Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Symposium Chairs: P. Levy (Grenoble, France), P. Lavie (Haifa, Israel)
Aims: This symposium will:
• identify early changes in cardiovascular function;
• identify early changes in metabolic function in the presence or absence of obesity;
• describe the major signalling pathways involved in inflammation and oxidative stress;
• evaluate the clinical value of biomarkers in the cardiovascular and metabolic fields;
• review possible therapeutic insights.